Category Archives: Pr Newswire

DiamiR Biosciences Secures EU Patent Covering the Use of microRNA Biomarkers from Bodily Fluids for Differential Diagnosis of Amyotrophic Lateral Sclerosis

NEW HAVEN, CT, and MONMOUTH JUNCTION, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) — DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that the Company’s European Patent Application No. 17 771018.3 titled: “Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases” was granted by […]

COUR Pharmaceuticals Announces Leadership Transition for Strategic Growth Objectives

Founder John J. Puisis to transition CEO role to current COO Dannielle Appelhans Mr. Puisis to remain on COUR Board of Directors CHICAGO, Aug. 01, 2024 (GLOBE NEWSWIRE) — COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed to induce antigen-specific tolerance for immune-mediated diseases, today announced that as part of a leadership […]

Non-invasive Vagus Nerve Stimulation (nVNS) is effective at accelerating foreign language learning

Clinical Trial demonstrates that nVNS is an effective learning acceleration tool while simultaneously improving focus and decreasing fatigue in study participants ROCKAWAY, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research Laboratories (AFRL) published a paper entitled “Transcutaneous Cervical Vagus […]

Galectin Therapeutics Appoints Khurram Jamil, M.D. to Chief Medical Officer

NORCROSS, Ga., Aug. 01, 2024 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced the appointment of Khurram Jamil, M.D., an accomplished senior executive with expertise in liver disease to Chief Medical Officer effective immediately. Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics, […]

Spinogenix Announces Open Enrollment for Phase 2 Study Evaluating SPG302 for the Treatment of Alzheimer’s Disease

SPG302 is a once-a-day pill with the potential to regenerate synapses to reverse declines in cognitive function in people with Alzheimer’s disease LOS ANGELES, Aug. 01, 2024 (GLOBE NEWSWIRE) — Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced that enrollment is now […]

Frost & Sullivan Institute Commends Visionary Companies with the 2024 Enlightened Growth Leadership Best Practices Recognition for Commitment to Sustainability and Growth Excellence

SANTA CLARA, Calif., Aug. 1, 2024 /PRNewswire/ — The Frost & Sullivan Institute is excited to unveil the 2024 Enlightened Leadership Best Practices Recognition winners from Middle East, Africa and Europe. These outstanding organizations have masterfully blended growth with their commitment to global stewardship. These exceptional companies, through their dedication to ‘innovating to zero’ to […]

Mega Matrix announced that “Misplaced Love”: Misaligned Emotions and the Serendipities of True Love, was first released on July 31!

PALO ALTO, Calif., Aug. 1, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced that it launched its highly anticipated short drama “Misplaced Love” on July 31st at FlexTV. Directed by a renowned vertical screen director and featuring a talented cast, this series blends the absurd with genuine emotion […]

HIGHWAY HOLDINGS REPORTS FIRST QUARTER FISCAL 2025 RESULTS; REVENUE INCREASES 39% YoY

HONG KONG , Aug. 1, 2024 /PRNewswire/ — Highway Holdings Limited (Nasdaq: HIHO) today reported financial results for the first quarter of fiscal year 2025 ended June 30, 2024. Net sales for the first quarter of fiscal year 2025 ended June 30, 2024 increased 39.3% to $1.88 million compared with $1.35 million in the first quarter […]

1,000+ Medical Device Manufacturing Leaders Gather at Medtec 2024

Experts Deliver Key Insights into Industry Trends SHANGHAI, Aug. 1, 2024 /PRNewswire/ — The Government Work Report releases in early 2024 emphasized the need to “explore new avenues in life sciences.” As a key area for developing new productivity, the medical device industry encompasses both the emerging high-end manufacturing sector and the future-focused healthcare sector. Medtec, […]

ZEEKR Announces July 2024 Delivery Update

HANGZHOU, China, Aug. 1, 2024 /PRNewswire/ — ZEEKR Intelligent Technology Holding Limited (“ZEEKR” or the “Company”) (NYSE: ZK), a fast-growing intelligent battery electric vehicle (“BEV”) technology company, today announced its delivery results for July 2024. ZEEKR delivered 15,655 vehicles in July 2024, marking a 30% year-over-year increase. Year-to-date, ZEEKR has delivered 103,525 vehicles in 2024, representing […]